NCT05826964 Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05780372 Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05763199 Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05755672 On-treatment Biomarkers in Metastatic Colorectal Cancer for Life Status RECRUITING Phase N/A
NCT05731947 Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05723107 EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) Status RECRUITING Phase PHASE1
NCT05718466 Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy Status COMPLETED Phase PHASE3
NCT05717166 A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. Status RECRUITING Phase PHASE3
NCT05710328 Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05704985 Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05704621 Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance Status RECRUITING Phase PHASE2
NCT05691829 Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC Status TERMINATED Phase PHASE2
NCT05684731 Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer Status RECRUITING Phase PHASE1
NCT05673148 Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study Status RECRUITING Phase PHASE3
NCT05667948 Molecular Analysis and Treatment Options of Thymic Malignancies Status RECRUITING Phase N/A
NCT05651802 PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients Status RECRUITING Phase NA
NCT05633602 Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05611359 Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer Status NOT_YET_RECRUITING Phase NA
NCT05607329 Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial Status RECRUITING Phase NA